TGA Approval To Commercially Manufacture Stem Cell Products
Filed with ASX · · 1 page · English
Earlier from Mesoblast
Later from Mesoblast
- Key Bone Repair Patent Granted in the United States
- Market Exclusivity Strengthened by New USA Healthcare Act
- MSB partner JCR files for product approval
- Mesoblast Cells Show Disease Modifying Effects on Knee OA
- Mesoblast Provides Q3 Financial Results and Corporate Update
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast